Nationale und deutschsprachige Leitlinien

Nationale Versorgungsleitlinie Asthma, Langfassung 4. Auflage, Klassifikation S3. Stand: 07.09.2020 , gültig bis 06.09.2025

https://www.awmf.org/uploads/tx_szleitlinien/nvl-002l_S3_Asthma_2020-09.pdf

Deutschsprachige 2-Länder-Leitlinie (D und AU)

Diagnostik und Therapie von Patienten mit Asthma. Registernummer 020 – 009. Klassifikation S2k. Stand: 12.09.2017 (in Überarbeitung), gültig bis 31.12.2020; sowie Addendum 2020.

https://www.awmf.org/leitlinien/detail/ll/020-009.html

https://www.awmf.org/fileadmin/user_upload/Leitlinien/020_D_Ges_fuer_Pneumologie/020-009add_S2k_Asthma_Diagnostik_Therapie_2020-12-abgelaufen.pdf

Internationale Leitlinien

Global Initiative for Asthma (GINA), Main Report 2021

https://ginasthma.org/wp-content/uploads/2021/05/GINA-Main-Report-2021-V2-WMS.pdf

Britische Leitlinien

https://www.brit-thoracic.org.uk/quality-improvement/guidelines/asthma/

Asthma: diagnosis, monitoring and chronic asthma management. NICE guideline [NG80] Published: 29 November 2017 Last updated: 22 March 2021

https://www.brit-thoracic.org.uk/document-library/guidelines/asthma/nice-guideline-asthma-diagnosis-monitoring-and-chronic-asthma-management/

BTS/SIGN Guideline for the management of asthma 2019

https://www.brit-thoracic.org.uk/document-library/guidelines/asthma/btssign-guideline-for-the-management-of-asthma-2019/

ERS Clinical practice guideline for the diagnosis of asthma in children aged 5-16 years. Gaillard E et al. Eur Respir J 2021 (ahead of print)

https://erj.ersjournals.com/content/early/2021/04/16/13993003.04173-2020

Spezielle Leitlinien Schwieriges und schweres Asthma

Internationale Leitlinien

ERS/ATS guideline 2020

Holguin F, Cardet JC, Chung KF, Diver S, Ferreira DS, Fitzpatrick A, Gaga M, Kellermeyer L, Khurana S, Knight S, McDonald VM, Morgan RL, Ortega VE, Rigau D, Subbarao P, Tonia T, Adcock IM, Bleecker ER, Brightling C, Boulet LP, Cabana M,Castro M, Chanez P, Custovic A, Djukanovic R, Frey U, Frankemölle B, Gibson P,Hamerlijnck D, Jarjour N, Konno S, Shen H, Vitary C, Bush A. Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2020 Jan 2;55(1):1900588. doi:10.1183/13993003.00588-2019. PMID: 31558662

Holguin F, Cardet JC, Chung KF, et al. Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J 2020; 55: 1900588 [https://doi.org/ 10.1183/13993003.00588-2019]

https://erj.ersjournals.com/content/erj/55/1/1900588.full.pdf

GINA

Diagnosis and management of difficult-to-treat and severe asthma, Version 3.0 (2021)

https://ginasthma.org/wp-content/uploads/2021/08/SA-Pocket-guide-v3.0-SCREEN-WMS.pdf

EAACI

Agache I et al. EAACI Biologicals Guidelines—Recommendations for severe asthma

https://medialibrary.eaaci.org/mediatheque/media.aspx?mediaId=84226&channel=8518

Andere relevante Leitlinien

Transition

EAACI Guidelines on the effective transition of adolescents and young adults with allergy and asthma. Roberts G et al. Allergy. 2020;75:2734–2752

https://onlinelibrary.wiley.com/doi/10.1111/all.14459

Transition von der Pädiatrie in die Erwachsenenmedizin

https://www.awmf.org/leitlinien/detail/ll/186-001.html